Delivery Order SPE2DX22D0010-SPE2D826FAV15
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,578.50 on August 4, 2025, for the supply of Methamphetamine HCL tablets (5mg). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Methamphetamine 5 mg tablets in quantities of 100 units. This competitive, non-set-aside contract carries a ceiling value of $3,677.92 and a firm fixed price structure, with an ultimate completion date of October 31, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,175.69, is for the delivery of methamphetamine hydrochloride tablets, 5mg, with a completion date of December 10, 2024. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Amphetamine Mix Tablets 5mg, with a ceiling value of $1,886.73 and a firm fixed price structure. The order is due for completion by August 4, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,989.00. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Amphetamine Mix Tablets 5mg, with a contract ceiling value of $1,080.39 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply action under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,247.04. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,217.90 for 100 tablets of Amphetamine 20mg from the Defense Logistics Agency's Medical Supply Chain on October 14, 2025, with completion targeted for October 15, 2025. This delivery order is issued under a firm fixed-price arrangement with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Amphetamine Mix Tablets 20mg with a ceiling value of $5,263.68. This firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Amphetamine Mix Tablets 15mg. This competitively awarded, non-set-aside delivery order carries a ceiling value of $4,108.42 and a firm fixed price structure, with an ultimate completion date of September 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAV15Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Methamphetamine HCL tablets (5mg) with a ceiling value of $15,931.83. This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 5, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical federal vendor supplying a comprehensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 11/4/25 |